The dysregulation of PRMT1 is associated with the occurrence and development of various diseases, including pulmonary fibrosis (Zakrzewicz et al., 2015), cardiovascular disease (Damiati, 2019), diabetes, nephropathy (Qian et al., 2018), and cancer (Cha and Jho, 2012; Stouth et al., 2017). The gene discussed is PRMT1; the disease is cancer.